WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents

Sébastien Ponnou; Sami Timimi; Xavier Briffault; Laura Batstra; Peter C Gøtzsche; François Gonon

doi:10.1016/S2215-0366(23)00392-9

WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents

Sébastien Ponnou^*, Sami Timimi, Xavier Briffault, Laura Batstra, Peter C Gøtzsche, François Gonon

^*Corresponding author voor dit werk

Ontwikkelings- en Gedragsstoornissen in Onderwijs en Zorg: Assessment en Interventie

Onderzoeksoutput › Academic › peer review

38 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	92-93
Aantal pagina's	2
Tijdschrift	The Lancet. Psychiatry
Volume	11
Nummer van het tijdschrift	2
DOI's	https://doi.org/10.1016/S2215-0366(23)00392-9
Status	Published - feb.-2024

Toegang tot document

10.1016/S2215-0366(23)00392-9

WHO Essential Medicines List and methylphenidate for ADHD in children and adolescentsFinal publisher's version, 71,1 KBLicentie: Taverne

Handle.net

Permanente koppeling

Citeer dit

@article{4fe9885947d24afaa8382c5d0a8e084e,

title = "WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents",

keywords = "Child, Humans, Adolescent, Methylphenidate/therapeutic use, Attention Deficit Disorder with Hyperactivity/drug therapy, Central Nervous System Stimulants/therapeutic use, World Health Organization",

author = "S{\'e}bastien Ponnou and Sami Timimi and Xavier Briffault and Laura Batstra and G{\o}tzsche, {Peter C} and Fran{\c c}ois Gonon",

year = "2024",

month = feb,

doi = "10.1016/S2215-0366(23)00392-9",

language = "English",

volume = "11",

pages = "92--93",

journal = "The Lancet. Psychiatry",

issn = "2215-0366",

publisher = "ELSEVIER SCI LTD",

number = "2",

}

TY - JOUR

T1 - WHO Essential Medicines List and methylphenidate for ADHD in children and adolescents

AU - Ponnou, Sébastien

AU - Timimi, Sami

AU - Briffault, Xavier

AU - Batstra, Laura

AU - Gøtzsche, Peter C

AU - Gonon, François

PY - 2024/2

Y1 - 2024/2

KW - Child

KW - Humans

KW - Adolescent

KW - Methylphenidate/therapeutic use

KW - Attention Deficit Disorder with Hyperactivity/drug therapy

KW - Central Nervous System Stimulants/therapeutic use

KW - World Health Organization

U2 - 10.1016/S2215-0366(23)00392-9

DO - 10.1016/S2215-0366(23)00392-9

M3 - Article

C2 - 38245022

SN - 2215-0366

VL - 11

SP - 92

EP - 93

JO - The Lancet. Psychiatry

JF - The Lancet. Psychiatry

IS - 2

ER -